GFAHP protein |
Herpesvirus 1 (HSV) |
mean IC50 4.1 μg/ml; at concentrations 30 and 60 μg/ml inhibited HSV-1 penetration by 83.7 % and 93.5 %, respectively; at concentrations 125 and 500 μg/ml reduced virus production |
[33] |
D-fraction |
hepatitis B virus (HBV) |
IC50 0.59 mg/ml; synergistic activity with IFN |
[34] |
β-glucan (MD-fraction) |
Human immunodeficiency virus (HIV) |
Among 35 patients, in 20 was an increase of CD4+ cell amount and in 10 was a decrease in viral load |
[35] |
Extract |
Enterovirus EV71 |
Inhibition of viral replication, viral VP1 protein expression and genomic RNA synthesis, at the concentration of 200 μg/ml and IC50 194.80 μg/ml |
[36] |
Heteropolysaccharide |
Enterovirus EV71 |
Inhibition of viral replication, viral VP1 protein expression and genomic RNA synthesis, at the concentration of 250 μg/ml |
[37] |
Extract |
Methicillin-resistant Staphylococcus aureus (MRSA) |
inhibition of the MRSA biofilm development, decrease of OD to 0.21 in comparison to the control group of 0.42 |
[38] |
Water extract |
Bacillus subtilis, Escherichia coli and S. aureus
|
zones of growth inhibition were 8.7, 10.2 and 12.4 mm, respectively |
[39] |
Polysaccharides |
S. aureus, E. coli, Listeria monocytogenes, Bacillus megaterium
|
MICs for polysaccharide IPS 2.5 mg/ml, 5 mg/ml, 5 mg/ml and 10 mg/ml, respectively; MICs for zinc polysaccharide <0.625 mg/ml, 1.25 mg/ml, 2.5 mg/ml, and 2.5 mg/ml, respectively. |
[42] |
D-fraction |
Listeria monocytogenes |
D-fraction at a dose 10 mg/kg per day improved the survival rate of Listeria-infected mice to 60 %; reduction of the number of Listeria in the peritoneal cavity by 33 % |
[43] |
Grifolaone A |
Fusarium oxysporum, Gibberella zeae, Piricularia oryzae, Pseudallescheria boydii |
MIC values of 2.5, 2.5, 0.15 and 1.25 μg/mL, respectively |
[44] |